GLP-1 drugs achieve some of these effects by directly affecting the brain’s cravings for food, and that might also extend to ...

While the drugs certainly contribute to weight loss and health gains, they also cause a decline in muscle that some doctors ...

The best metric is not weight, but a particularly toxic kind of fat.

New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more ...

David Kessler has lost more than 60 pounds on weight-loss drugs and believes they can change the trajectory of chronic ...

Weight-loss injections, or GLP-1 receptor agonists, could nearly halve the risk of obesity-related cancers, a new study finds ...

New research being presented at the European Congress on Obesity (ECO 2025) has found that patients of an online obesity ...

Prescription drug spending in the United States rose by 10.2% last year, thanks in part to the popularity of GLP weight-loss ...

A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

Reducing exposure to medicines is always a good thing if similar clinical outcomes can be achieved, and the study suggests it ...

While GLP-1 receptor agonists and bariatric surgery offer significant metabolic benefits, experts caution that rapid weight ...

New research being presented at the European Congress on Obesity (ECO25) in Malaga, Spain (11–14 May) and published in the ...